User profiles for "author:Monica Jones"

Monica LH Jones

University of Michigan
Verified email at umich.edu
Cited by 662

Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging

A Mariani, SC Dowdy, WA Cliby, BS Gostout… - Gynecologic …, 2008 - Elsevier
OBJECTIVE: To prospectively assess pelvic and para-aortic lymph node metastases in
endometrial cancer with lymphatic dissemination, emphasizing the examination of para …

Aggressive surgical effort and improved survival in advanced-stage ovarian cancer

GD Aletti, SC Dowdy, BS Gostout, MB Jones… - Obstetrics & …, 2006 - journals.lww.com
OBJECTIVE: Residual disease after initial surgery for ovarian cancer is the strongest
prognostic factor for survival. However, the extent of surgical resection required to achieve …

PARP inhibitors in the management of ovarian cancer: ASCO guideline

WP Tew, C Lacchetti, A Ellis, K Maxian… - Obstetrical & …, 2020 - journals.lww.com
Despite advances in diagnosis and therapy, an individual with ovaries carries an
approximate 1 in 108 lifetime chance to die due to ovarian cancer (OC). Primary therapy …

Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer

MB Jones, H Krutzsch, H Shu, Y Zhao… - PROTEOMICS …, 2002 - Wiley Online Library
Epithelial ovarian cancer kills almost 16 000 women each year in part due to late stage of
presentation and lack of reliable biomarkers for disease detection. CA‐125, the currently …

Static, dynamic, and cognitive fit of exosystems for the human operator

L Stirling, D Kelty-Stephen, R Fineman… - Human …, 2020 - journals.sagepub.com
Objective To define static, dynamic, and cognitive fit and their interactions as they pertain to
exosystems and to document open research needs in using these fit characteristics to inform …

Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer …

AG Lai, L Pasea, A Banerjee, G Hall, S Denaxas… - BMJ open, 2020 - bmjopen.bmj.com
Objectives To estimate the impact of the COVID-19 pandemic on cancer care services and
overall (direct and indirect) excess deaths in people with cancer. Methods We employed …

Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency

AG Lai, L Pasea, A Banerjee, S Denaxas, M Katsoulis… - MedRxiv, 2020 - medrxiv.org
Background Cancer and multiple non-cancer conditions are considered by the Centers for
Disease Control and Prevention (CDC) as high risk conditions in the COVID-19 emergency …

Borderline ovarian tumors: current concepts for prognostic factors and clinical management

MB Jones - Clinical obstetrics and gynecology, 2006 - journals.lww.com
Since their original description in 1929, our knowledge of the natural history and molecular
pathology of borderline ovarian tumors (BOTs) has advanced most dramatically over the last …

Efficacy and mechanism-of-action of a novel superagonist interleukin-15: interleukin-15 receptor αSu/Fc fusion complex in syngeneic murine models of multiple …

W Xu, M Jones, B Liu, X Zhu, CB Johnson, AC Edwards… - Cancer research, 2013 - AACR
ALT-803, a complex of an interleukin (IL)-15 superagonist mutant and a dimeric IL-15
receptor αSu/Fc fusion protein, was found to exhibit significantly stronger in vivo biologic …

Phase I trial of ALT-803, a novel recombinant IL15 complex, in patients with advanced solid tumors

K Margolin, C Morishima, V Velcheti, JS Miller… - Clinical Cancer …, 2018 - AACR
Purpose: IL15 induces the activation and proliferation of natural killer (NK) and memory
CD8+ T cells and has preclinical antitumor activity. Given the superior activity and favorable …